# 5 Alarm Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/5-alarm-bio

- Industry: Pharmaceuticals
- Headquarters: Cambridge, UK
- Website: www.fivealarmbio.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Jul 12, 2022)
- Investors on record: 5

## About

Based in Cambridge, UK, and founded in 2016 by co-founder and CEO Dr. Janette Thomas, and Sunil Shah, Five Alarm Bio Limited, d.b.a. 5 Alarm Bio is a pharmaceutical company that intends to develop an innovative small molecule approach aimed at boosting anti-aging to extend the healthy lifespan of individuals. In February 2023, 5 Alarm Bio raised GBP 0.5 million in seed funding from Acceleris, Cambridge Angels Group, Meltwind, O2h Ventures, and SyndicateRoom.

The company is developing a small molecule approach to boost the body’s defense against aging, based on a new understanding of how the chemical damage associated with age accumulates in cells.

Alarm Bio plans to use its proceeds from February 2023 funding to research novel compounds that extend the healthy lifespan of cells and tissues, with therapeutic potential across a broad range of age-related diseases.

## Funding rounds

- Seed, Jul 12, 2022, $0.8M — Cambridge Angels Group, Acceleris, SyndicateRoom, O2h Ventures, Meltwind

## Investors

- Cambridge Angels Group — Seed
- Acceleris (https://capitalatlas.ai/funds/acceleris) — Seed
- SyndicateRoom (https://capitalatlas.ai/funds/syndicateroom) — Seed
- O2h Ventures (https://capitalatlas.ai/funds/o2h-ventures) — Seed
- Meltwind — Seed